Early-phase data support dose-optimized subcutaneous blinatumomab as a promising approach for relapsed or refractory B-cell ...

A promising clinical trial shows that a combination of paxalisib, pembrolizumab, and chemotherapy significantly reduces circulating tumor cells in metastatic triple-negative breast cancer.

Kazia Therapeutics (NASDAQ:KZIA) on Wednesday reported preliminary results from the first patient in its Phase 1b trial ...

If measured from beginning to end, the DNA in our cells is too long to fit into the cell's nucleus, explaining why it must be ...

Fujifilm’s Life Sciences Group is renaming two of its companies, in a rebranding intended to position parent company Fujifilm ...

Platelet-derived growth factors can restore the proliferative potential of senescent cells taken from the degenerated intervertebral discs of aged humans.

Scientists have identified dozens of human proteins that SARS-CoV-2, the virus that causes COVID-19, depends on to replicate ...

Next-generation sequencing (NGS) has proven to be a powerful tool for early cancer detection. Among its many uses, NGS can be used to interrogate fragments of circulating cell-free DNA—leaked into the ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered ...

Based in the College of Veterinary Medicine, the team found that the bacteria can manipulate a protein known as ATF6, which helps cells detect and respond to ... to new methods for interrupting the ...

Data retention and its statistics are the key issues for the development of next generation phase-change memory (PCM) arrays. For this reason, the understanding and modeling of cell-to-cell and ...

Everyone’s menstrual cycle is different. This guide describes what’s normal, how to manage symptoms and optimize your health, and what abnormalities to watch out for.